DLX6 and neoplasm: For validation, tumorigenesis in mice is conducted to highlight that down‐regulating DLX6‐AS1 or up‐regulating miR‐193b‐3p depresses tumour formation and miR‐193b‐3p inhibition would negate DLX6‐AS1 down‐regulation‐contributed impacts on tumour weight and volume.